{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:27:31Z","timestamp":1783474051543,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s12020-021-02751-9","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T12:02:41Z","timestamp":1621598561000},"page":"667-673","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Prevalence of vertebral fractures and serum sclerostin levels in acromegaly"],"prefix":"10.1007","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6569-8142","authenticated-orcid":false,"given":"Meliha Melin","family":"Uygur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5603-0004","authenticated-orcid":false,"given":"Dilek Dereli","family":"Yaz\u0131c\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6011-2720","authenticated-orcid":false,"given":"Onur","family":"Bu\u011fdayc\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0075-6313","authenticated-orcid":false,"given":"Dilek Gogas","family":"Yavuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,21]]},"reference":[{"issue":"1","key":"2751_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41572-019-0071-6","volume":"5","author":"A Colao","year":"2019","unstructured":"A. Colao, L.F.S. Grasso, A. Giustina, S. Melmed, P. Chanson, A.M. Pereira et al. Acromegaly. Nat. Rev. Dis. Prim. 5(1), 20 (2019)","journal-title":"Nat. Rev. Dis. Prim."},{"key":"2751_CR2","doi-asserted-by":"crossref","unstructured":"M. Cellini, E. Biamonte, M. Mazza, N. Trenti, P. Ragucci, D. Milani et al. Vertebral fractures associated with spinal sagittal imbalance and quality of life in acromegaly: a radiographic study with Eos 2d\/3d technology. Neuroendocrinology (2020)","DOI":"10.1159\/000511811"},{"issue":"2","key":"2751_CR3","doi-asserted-by":"publisher","first-page":"R45","DOI":"10.1530\/EJE-19-0184","volume":"181","author":"G Mazziotti","year":"2019","unstructured":"G. Mazziotti, A.G.A. Lania, E. Canalis, Management of endocrine disease: bone disorders associated with acromegaly: mechanisms and treatment. Eur. J. Endocrinol. 181(2), R45\u2013R56 (2019)","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"2751_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1210\/er.2007-0036","volume":"29","author":"A Giustina","year":"2008","unstructured":"A. Giustina, G. Mazziotti, E. Canalis, Growth hormone, insulin-like growth factors, and the skeleton. Endocr. Rev. 29(5), 535\u201359 (2008)","journal-title":"Endocr. Rev."},{"issue":"10","key":"2751_CR5","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1359\/JBMR.050603","volume":"20","author":"S Bonadonna","year":"2005","unstructured":"S. Bonadonna, G. Mazziotti, M. Nuzzo, A. Bianchi, A. Fusco, L. De Marinis et al. Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. J. Bone Min. Res. 20(10), 1837\u201344 (2005)","journal-title":"J. Bone Min. Res."},{"issue":"2","key":"2751_CR6","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1210\/jc.2014-2937","volume":"100","author":"G Mazziotti","year":"2015","unstructured":"G. Mazziotti, E. Biagioli, F. Maffezzoni, M. Spinello, V. Serra, R. Maroldi et al. Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis. J. Clin. Endocrinol. Metab. 100(2), 384\u201394 (2015)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"2751_CR7","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.1210\/jc.2008-0791","volume":"93","author":"G Mazziotti","year":"2008","unstructured":"G. Mazziotti, A. Bianchi, S. Bonadonna, V. Cimino, I. Patelli, A. Fusco et al. Prevalence of vertebral fractures in men with acromegaly. J. Clin. Endocrinol. Metab. 93(12), 4649\u201355 (2008)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"2751_CR8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1530\/EJE-10-1005","volume":"164","author":"M Wassenaar","year":"2011","unstructured":"M. Wassenaar, N. Biermasz, N. Hamdy, M. Zillikens, J. Van Meurs, F. Rivadeneira et al. High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly. Eur. J. Endocrinol. 164(4), 475 (2011)","journal-title":"Eur. J. Endocrinol."},{"issue":"12","key":"2751_CR9","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.1210\/jc.2013-2695","volume":"98","author":"K Claessen","year":"2013","unstructured":"K. Claessen, H. Kroon, A. Pereira, N. Appelman-Dijkstra, M. Verstegen, M. Kloppenburg et al. Progression of vertebral fractures despite long-term biochemical control of acromegaly: a prospective follow-up study. J. Clin. Endocrinol. Metab. 98(12), 4808\u201315 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"2751_CR10","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1210\/jc.2013-1460","volume":"98","author":"G Mazziotti","year":"2013","unstructured":"G. Mazziotti, A. Bianchi, T. Porcelli, M. Mormando, F. Maffezzoni, A. Cristiano et al. Vertebral fractures in patients with acromegaly: a 3-year prospective study. J. Clin. Endocrinol. Metab. 98(8), 3402\u201310 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2751_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1210\/clinem\/dgz096","volume":"105","author":"A Giustina","year":"2020","unstructured":"A. Giustina, A. Barkan, A. Beckers, N. Biermasz, B.M.K. Biller, C. Boguszewski et al. A consensus on the diagnosis and treatment of acromegaly comorbidities: an update. J. Clin. Endocrinol. Metab. 105, 4 (2020)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2751_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bone.2016.10.007","volume":"96","author":"J Delgado-Calle","year":"2017","unstructured":"J. Delgado-Calle, A.Y. Sato, T. Bellido, Role and mechanism of action of sclerostin in bone. Bone 96, 29\u201337 (2017)","journal-title":"Bone"},{"issue":"10","key":"2751_CR13","doi-asserted-by":"publisher","first-page":"e25900","DOI":"10.1371\/journal.pone.0025900","volume":"6","author":"AR Wijenayaka","year":"2011","unstructured":"A.R. Wijenayaka, M. Kogawa, H.P. Lim, L.F. Bonewald, D.M. Findlay, G.J. Atkins, Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway. PLoS ONE 6(10), e25900 (2011)","journal-title":"PLoS ONE"},{"issue":"2","key":"2751_CR14","doi-asserted-by":"publisher","first-page":"R167","DOI":"10.1530\/JME-18-0176","volume":"62","author":"G Holdsworth","year":"2019","unstructured":"G. Holdsworth, S.J. Roberts, H.Z. Ke, Novel actions of sclerostin on bone. J. Mol. Endocrinol. 62(2), R167\u2013R85 (2019)","journal-title":"J. Mol. Endocrinol."},{"issue":"5","key":"2751_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1056\/NEJMoa1305224","volume":"370","author":"M McLung","year":"2014","unstructured":"M. McLung, A. Frauer, S. Boonen, Romosozumab in postmenopausal women with low bone mineral density. N. Engl. J. Med 370(5), 412\u201320 (2014)","journal-title":"N. Engl. J. Med"},{"issue":"3","key":"2751_CR16","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/jbmr.3923","volume":"35","author":"KA Carpenter","year":"2020","unstructured":"K.A. Carpenter, R.D. Ross, Sclerostin antibody treatment increases bone mass and normalizes circulating phosphate levels in growing Hyp mice. J. Bone Miner. Res. 35(3), 596\u2013607 (2020)","journal-title":"J. Bone Miner. Res."},{"issue":"9","key":"2751_CR17","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","volume":"8","author":"HK Genant","year":"1993","unstructured":"H.K. Genant, C.Y. Wu, C. Van Kuijk, M.C. Nevitt, Vertebral fracture assessment using a semiquantitative technique. J. Bone Miner. Res. 8(9), 1137\u201348 (1993)","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"2751_CR18","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jocd.2012.06.002","volume":"16","author":"M Madeira","year":"2013","unstructured":"M. Madeira, L.V. Neto, C.H. Torres, L.M.C. de Mendon\u00e7a, M.R. Gadelha, M.L.F. de Farias, Vertebral fracture assessment in acromegaly. J. Clin. Densitom. 16(2), 238\u201343 (2013)","journal-title":"J. Clin. Densitom."},{"issue":"4","key":"2751_CR19","doi-asserted-by":"publisher","first-page":"e937","DOI":"10.1210\/clinem\/dgz096","volume":"105","author":"A Giustina","year":"2020","unstructured":"A. Giustina, A. Barkan, A. Beckers, N. Biermasz, B.M. Biller, C. Boguszewski et al. A consensus on the diagnosis and treatment of acromegaly comorbidities: an update. J. Clin. Endocrinol. Metab. 105(4), e937\u2013e46 (2020)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"2751_CR20","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1210\/clinem\/dgz254","volume":"105","author":"Z Pekkolay","year":"2020","unstructured":"Z. Pekkolay, F. K\u0131l\u0131n\u00e7, N. Gozel, E. \u00d6nalan, A.K. Tuzcu, Increased serum sclerostin levels in patients with active acromegaly. J. Clin. Endocrinol. Metab. 105(3), 920\u20134 (2020)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2751_CR21","doi-asserted-by":"crossref","unstructured":"J. Halupczok-\u017by\u0142a, A. Jawiarczyk-Przyby\u0142owska, A. Zembska, M. Bolanowski (eds) Sclerostin and fracture risk assessment in acromegaly. 21st European Congress of Endocrinology (BioScientifica, 2019)","DOI":"10.1530\/endoabs.63.GP56"},{"issue":"9588","key":"2751_CR22","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(07)61342-7","volume":"370","author":"BM Tang","year":"2007","unstructured":"B.M. Tang, G.D. Eslick, C. Nowson, C. Smith, A. Bensoussan, Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 370(9588), 657\u201366 (2007)","journal-title":"Lancet"},{"issue":"3","key":"2751_CR23","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1210\/clinem\/dgz054","volume":"105","author":"S Chiloiro","year":"2020","unstructured":"S. Chiloiro, A. Giampietro, S. Frara, C. Bima, F. Donfrancesco, C.M. Fleseriu et al. Effects of pegvisomant and pasireotide LAR on vertebral fractures in acromegaly resistant to first-generation SRLs. J. Clin. Endocrinol. Metab. 105(3), e100\u2013e7 (2020)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2751_CR24","doi-asserted-by":"publisher","first-page":"101335","DOI":"10.1016\/j.ghir.2020.101335","volume":"55","author":"MM Uygur","year":"2020","unstructured":"M.M. Uygur, O. Deyneli, D.G. Yavuz, Long-term endocrinological outcomes of gamma knife radiosurgery in acromegaly patients. Growth Horm. IGF Res. 55, 101335 (2020)","journal-title":"Growth Horm. IGF Res."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02751-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-021-02751-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02751-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T09:21:18Z","timestamp":1627723278000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-021-02751-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,21]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["2751"],"URL":"https:\/\/doi.org\/10.1007\/s12020-021-02751-9","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,21]]},"assertion":[{"value":"4 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}